Warm autoimmune hemolytic anemia
Information
- Disease name
- Warm autoimmune hemolytic anemia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03226678 | Completed | Phase 2 | Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With Warm Type Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD) | August 31, 2017 | September 12, 2022 |
| NCT01181154 | Completed | Phase 3 | Rituximab in Auto-Immune Hemolytic Anemia | March 3, 2011 | January 8, 2016 |
| NCT05925023 | Recruiting | Phase 2 | Sirolimus in the Treatment of Refractory/Relapsed wAIHA | June 24, 2023 | December 2025 |
| NCT04119050 | Recruiting | Phase 2/Phase 3 | Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia | August 15, 2019 | April 10, 2028 |
| NCT05757570 | Recruiting | Phase 1/Phase 2 | An Open-label Study of Povetacicept in Subjects With Autoimmune Cytopenias | July 3, 2023 | November 2027 |
| NCT05786573 | Recruiting | Phase 3 | A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre) | September 25, 2023 | June 8, 2026 |
| NCT05922839 | Recruiting | Phase 2 | Zanubrutinib in the Treatment of Relapsed/Refractory wAIHA | November 11, 2023 | December 2025 |
| NCT05221619 | Temporarily not available | Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA) | |||
| NCT03075878 | Terminated | Phase 1/Phase 2 | A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA) | January 10, 2018 | August 6, 2019 |
| NCT04253236 | Terminated | Phase 2 | To Assess the Efficacy and Safety of RVT-1401 in the Treatment of Warm Autoimmune Hemolytic Anemia (ASCEND-WAIHA). | August 11, 2020 | April 1, 2021 |
| NCT04956276 | Withdrawn | Phase 2 | Subcutaneous ALXN1830 in Adult Participants With Warm Autoimmune Hemolytic Anemia | January 1, 2022 | July 31, 2024 |
| NCT03965624 | Withdrawn | Phase 2 | Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia | September 1, 2019 | September 1, 2023 |
| NCT04256148 | Withdrawn | Phase 2 | ALXN1830 in Patients With Warm Autoimmune Hemolytic Anemia | July 2021 | April 30, 2023 |